LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization

The leucine-rich repeat kinase 2 (LRRK2) gene was found to play a role in the pathogenesis of both familial and sporadic Parkinson’s disease (PD). LRRK2 encodes a large multi-domain protein that is expressed in different tissues. To date, the physiological and pathological functions of LRRK2 are not clearly defined. In this study we have explored the role of LRRK2 in controlling vesicle trafficking in different cellular or animal models and using various readouts. In neuronal cells, the presence of LRRK2G2019S pathological mutant determines increased extracellular dopamine levels either under basal conditions or upon nicotine stimulation. Moreover, mutant LRRK2 affects the levels of dopamine receptor D1 on the membrane surface in neuronal cells or animal models. Ultrastructural analysis of PC12-derived cells expressing mutant LRRK2G2019S shows an altered intracellular vesicle distribution. Taken together, our results point to the key role of LRRK2 to control vesicle trafficking in neuronal cells.

• Publication year

  2013

• Venue

  PLoS ONE

• Publication date

  2013-10-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0077198PMID 24167564PMCID 3805556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ArfGAP1 Is a GTPase Activating Protein for LRRK2: Reciprocal Regulation of ArfGAP1 by LRRK2

  2012cited by this paper
• LRRK2 and vesicle trafficking.

  2012cited by this paper
• Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway

  2012cited by this paper
• LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth

  2012cited by this paper
• LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.

  2012cited by this paper
• Synaptic vesicle trafficking and Parkinson's disease

  2012cited by this paper
• Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2

  2011cited by this paper
• Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine Reuptake

  2011cited by this paper
• Etiology and pathogenesis of Parkinson's disease

  2011cited by this paper
• Endocytosis promotes rapid dopaminergic signaling.

  2011cited by this paper
• LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool

  2011cited by this paper
• The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease

  2011cited by this paper
• Bcl2-A1 interacts with pro-caspase-3: implications for amyotrophic lateral sclerosis.

  2011cited by this paper
• Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

  2010cited by this paper
• Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S

  2010cited by this paper
• Coordinate Regulation of Neurite Outgrowth by LRRK2 and Its Interactor, Rab5

  2010cited by this paper
• Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.

  2010cited by this paper
• Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions

  2009cited by this paper
• Leucine‐rich repeat kinase 2 phosphorylates brain tubulin‐beta isoforms and modulates microtubule stability – a point of convergence in Parkinsonian neurodegeneration?

  2009cited by this paper
• Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease

  2009cited by this paper
• Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis

  2009cited by this paper
• LRRK2 regulates synaptic vesicle endocytosis.

  2008cited by this paper
• Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

  2008cited by this paper
• Extracellular dopamine induces the oxidative toxicity of SH‐SY5Y cells

  2008cited by this paper
• The Roco protein family: a functional perspective

  2008cited by this paper
• Overexpression of APP stimulates basal and constitutive exocytosis in PC12 cells.

  2008cited by this paper
• Genes associated with Parkinson syndrome

  2008cited by this paper
• Novel integrated microdialysis-amperometric system for in vitro detection of dopamine secreted from PC12 cells: design, construction, and validation.

  2008cited by this paper
• Phosphorylation of 4E‐BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila

  2008cited by this paper
• Apoptotic mechanisms in mutant LRRK2-mediated cell death.

  2007cited by this paper
• Leucine-rich repeat kinase 2 associates with lipid rafts.

  2007cited by this paper
• Localization of LRRK2 to membranous and vesicular structures in mammalian brain

  2006cited by this paper
• Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.

  2006cited by this paper
• AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse

  2006cited by this paper
• Kinase activity of mutant LRRK2 mediates neuronal toxicity

  2006cited by this paper
• The pleomorphic pathology of inherited parkinson’s disease: Lessons from LRRK2

  2006cited by this paper
• Synaptic vesicle pools

  2005cited by this paper
• Differential signaling in presynaptic neurotransmitter release

  2005cited by this paper
• Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.

  2005cited by this paper
• [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

  2004cited by this paper
• The Structural Organization of the Readily Releasable Pool of Synaptic Vesicles

  2004cited by this paper
• Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

  2004cited by this paper
• Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

  2004cited by this paper
• Role of the nitric oxide/cyclic GMP pathway and extracellular environment in the nitric oxide donor‐induced increase in dopamine secretion from PC12 cells: a microdialysis in vitro study

  2003influential reference
• PC12 cells as a model for studies of regulated secretion in neuronal and endocrine cells.

  2003cited by this paper
• Role of the nitric oxide/cyclic GMP pathway and ascorbic acid in 3-morpholinosydnonimine (SIN-1)-induced increases in dopamine secretion from PC12 cells. A microdialysis in vitro study.

  2003cited by this paper
• Regulation of neuronal function by protein trafficking: a role for the endosomal pathway

  2000cited by this paper
• Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis.

  2000cited by this paper
• Enhancing Effect of Manganese on L‐DOPA‐Induced Apoptosis in PC12 Cells

  1999cited by this paper
• Dopamine receptors: from structure to function.

  1998cited by this paper
• Transient transfection studies of secretion in bovine chromaffin cells and PC12 cells. Generation of kainate-sensitive chromaffin cells.

  1993cited by this paper
• In vitro microdialysis: a novel technique for stimulated neurotransmitter release measurements.

  1991cited by this paper
• Regulation of the differentiation of PC12 pheochromocytoma cells.

  1989cited by this paper
• Selective MAO A and B inhibitors: their mechanism of action and pharmacology.

  1983cited by this paper
• Isolation and characterization of chromaffin granules from a pheochromocytoma (PC 12) cell line.

  1980cited by this paper
• Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line.

  1980cited by this paper

• Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice.

  2025cites this paper
• Targeting the LRRK2 G2019S Mutation Found in Parkinson's Disease: Efficiency of Biosynthesized Solid Lipid Nanoparticles for Therapeutic siRNA-Mediated Gene Therapy.

  2025cites this paper
• Generation of Leucine-Rich Repeat Kinase 2 (LRRK2) Knockout Neuroblastoma Cells SH-SY5Y by CRISPR/Cas9-Mediated Genome Editing.

  2025cites this paper
• Two- and Three-Dimensional In Vitro Models of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Applications

  2025cites this paper
• Therapeutic Effect of Padina arborescens Extract on a Cell System Model for Parkinson’s Disease

  2024cites this paper
• LRRK2 Attenuates Antioxidant Response in Familial Parkinson’s Disease Derived Neural Stem Cells

  2023cites this paper
• Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain

  2023cites this paper
• Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects

  2023cites this paper
• Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease

  2023cites this paper
• STING signaling in the brain: Molecular threats, signaling activities, and therapeutic challenges.

  2023cites this paper
• Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons

  2022cites this paper
• Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease

  2022cites this paper
• Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define diagnostic and prognostic biosignatures for Parkinson's Disease

  2022cites this paper
• Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease

  2022cites this paper
• Leucine-rich repeat kinase 2 limits dopamine D1 receptor signaling in striatum and biases against heavy persistent alcohol drinking

  2022cites this paper
• LRRK2 along the Golgi and lysosome connection: a jamming situation

  2021cites this paper
• LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8

  2021cites this paper
• Conformation and Dynamics of the Kinase Domain Drive Subcellular Location and Activation of LRRK2.

  2021cites this paper
• In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity.

  2021cites this paper
• In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition

  2021cites this paper
• Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics

  2020influential citation
• LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons

  2020cites this paper
• Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’s Disease

  2020cites this paper
• Conformation and Dynamics of the Kinase Domain Drive Subcellular Location and Activation of LRRK2.

  2020cites this paper
• Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation.

  2020cites this paper
• The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity

  2020cites this paper
• LRRK2 and the Endolysosomal System in Parkinson’s Disease

  2020cites this paper
• A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2

  2020cites this paper
• From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2

  2020cites this paper
• Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2

  2020cites this paper
• DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism‐Dystonia

  2020cites this paper
• Initiation and Transmission of α-Synuclein Pathology in Parkinson’s Disease

  2019cites this paper
• Neuronal KIF5b deletion induces striatum‐dependent locomotor impairments and defects in membrane presentation of dopamine D2 receptors

  2019cites this paper
• Induced pluripotent stem cell‐based modeling of mutant LRRK2‐associated Parkinson's disease

  2019cites this paper
• Non-Cell Autonomous Mechanism of Parkinson's Disease Pathology Caused by G2019S LRRK2 Mutation in Ashkenazi Jewish Patient: Single Cell Analysis.

  2019cites this paper
• Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype

  2019cites this paper
• Leucine‐rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson disease

  2019cites this paper
• Back to the origins: human brain organoids to investigate neurodegeneration.

  2019cites this paper
• The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagation.

  2019cites this paper
• Structural aspects of the regulation of Parkinson's Disease-associated LRRK2 Kinase by Rab GTPases

  2019cites this paper
• Understanding Neurodegeneration and Neuroprotection Through Genetic Screens in Drosophila

  2019cites this paper
• Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2G2019S-Parkinson’s disease

  2018cites this paper
• Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease.

  2018cites this paper
• LRRK2 deficiency impairs trans-Golgi to lysosome trafficking and endocytic cargo degradation in human renal proximal tubule epithelial cells.

  2018cites this paper
• Brain injury induces HIF-1α-dependent transcriptional activation of LRRK2 that exacerbates brain damage

  2018cites this paper
• Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease

  2018cites this paper
• The impact of murine LRRK2 G2019S transgene overexpression on acute responses to inflammatory challenge.

  2018cites this paper
• Impaired intracortical transmission in G2019S leucine rich‐repeat kinase Parkinson patients

  2017influential citation
• Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient‐derived induced pluripotent stem cells

  2017cites this paper
• Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila

  2017cites this paper
• The role of LRRK2 in the pathogenesis of Parkinson's disease

  2017cites this paper
• Role of LRRK2 in the regulation of dopamine receptor trafficking

  2017cites this paper
• Synthesis of Nitric Oxide Donors Derived from Piloty’s Acid and Study of Their Effects on Dopamine Secretion from PC12 Cells

  2017cites this paper
• A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway

  2017cites this paper
• Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice

  2017cites this paper
• LRRK2 Regulates Voltage-Gated Calcium Channel Function

  2016cites this paper
• Elucidating the Role of LRRK2 in the Central Nervous System: An Examination of Toxin-Induced Neuronal Outcomes

  2016cites this paper
• Systematic literature review on Parkinson's disease and Childhood Leukaemia and mode of actions for pesticides

  2016cites this paper
• I 2020 T mutant LRRK 2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT / GSK-3 β signaling pathway

  2015cites this paper
• A visual review of the interactome of LRRK2: Using deep-curated molecular interaction data to represent biology

  2015cites this paper
• Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain

  2015cites this paper
• Cellular processes associated with LRRK2 function and dysfunction

  2015cites this paper
• Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau.

  2015cites this paper
• Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice.

  2015cites this paper
• Control of Autophagy in Parkinson’s Disease

  2015cites this paper
• Rodent Models of Autosomal Dominant Parkinson Disease

  2015cites this paper
• Changes in actin dynamics and F-actin structure both in synaptoneurosomes of LRRK2(R1441G) mutant mice and in primary human fibroblasts of LRRK2(G2019S) mutation carriers.

  2015cites this paper
• I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway.

  2015cites this paper
• LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?

  2014cites this paper
• Novel insights into the neurobiology underlying LRRK2-linked Parkinson's disease.

  2014cites this paper
• Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging

  2014cites this paper
• LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex

  2014cites this paper
• LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.

  2014cites this paper
• LRRK 2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab 7 activity

  2014cites this paper